| Source | Code | Name | Case count | Share of cases (%) |
|---|---|---|---|---|
| PURCH | PURCH_ATC(A10BA02) | Metformin | 43387 | |
| REIMB | REIMB_KELA(103)_ICD10(E11) | Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus | 29905 | |
| REIMB | REIMB_KELA(215)_ICD10(E11) | Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus | 27386 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(E11) | Non-insulin-dependent diabetes mellitus. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 23029 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(E119) | Non-insulin-dependent diabetes mellitus - Without complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 20106 | |
| OUTPAT | OUTPAT_ICD10(E119) | Non-insulin-dependent diabetes mellitus - Without complications | 17820 | |
| INPAT | INPAT_ICD10(E119) | Non-insulin-dependent diabetes mellitus - Without complications | 16960 | |
| PURCH | PURCH_ATC(A10BH01) | Sitagliptin | 12548 | |
| PURCH | PURCH_ATC(A10BB12) | Glimepiride | 9188 | |
| PURCH | PURCH_ATC(A10BK03) | Empagliflozin | 6122 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(E118) | Non-insulin-dependent diabetes mellitus - With unspecified complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 5263 | |
| REIMB | REIMB_KELA(103)_ICD10(E119) | Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - Without complications | 4893 | |
| PURCH | PURCH_ATC(A10BD07) | Metformin and sitagliptin | 4865 | |
| INPAT | INPAT_ICD10(E118) | Non-insulin-dependent diabetes mellitus - With unspecified complications | 4778 | |
| REIMB | REIMB_KELA(215)_ICD10(E119) | Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - Without complications | 4764 | |
| PURCH | PURCH_ATC(A10BH05) | Linagliptin | 4507 | |
| PURCH | PURCH_ATC(A10BB01) | Glibenclamide | 4308 | |
| OUTPAT | OUTPAT_ICD10(E118) | Non-insulin-dependent diabetes mellitus - With unspecified complications | 3956 | |
| PURCH | PURCH_ATC(A10BK01) | Dapagliflozin | 3217 | |
| PURCH | PURCH_ATC(A10BX01) | Guar gum | 3135 | |
| REIMB | REIMB_KELA(285)_ICD10(E11) | Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus | 2706 | |
| REIMB | REIMB_KELA(346)_ICD10(E11) | Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus | 2509 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(E117) | Non-insulin-dependent diabetes mellitus - With multiple complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 2478 | |
| PURCH | PURCH_ATC(A10BG03) | Pioglitazone | 2471 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(E112) | Non-insulin-dependent diabetes mellitus - With renal complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 2393 | |
| INPAT | INPAT_ICD10(E1100) | Non-insulin dependent diabetes diabetic hypoglycaemic coma | 2371 | |
| OUTPAT | OUTPAT_ICD10(E117) | Non-insulin-dependent diabetes mellitus - With multiple complications | 2257 | |
| PURCH | PURCH_ATC(A10BJ02) | Liraglutide | 2188 | |
| INPAT | INPAT_ICD10(E117) | Non-insulin-dependent diabetes mellitus - With multiple complications | 2099 | |
| PURCH | PURCH_ATC(A10BH02) | Vildagliptin | 1958 | |
| OUTPAT | OUTPAT_ICD10(E113) | Non-insulin-dependent diabetes mellitus - With ophthalmic complications | 1896 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(E114) | Non-insulin-dependent diabetes mellitus - With neurological complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 1832 | |
| REIMB | REIMB_KELA(160)_ICD10(E11) | exenatide, Non-insulin-dependent diabetes mellitus | 1721 | |
| DEATH | DEATH_ICD10(E119) | Non-insulin-dependent diabetes mellitus - Without complications | 1713 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(E113) | Non-insulin-dependent diabetes mellitus - With ophthalmic complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 1614 | |
| INPAT | INPAT_ICD9(2500A) | Diabetes mellitus without mention of complication | 1579 | |
| OUTPAT | OUTPAT_ICD10(E11) | Non-insulin-dependent diabetes mellitus | 1482 | |
| PURCH | PURCH_ATC(A10BD03) | Metformin and rosiglitazone | 1411 | |
| PURCH | PURCH_ATC(A10BG02) | Rosiglitazone | 1323 | |
| OUTPAT | OUTPAT_ICD10(E112) | Non-insulin-dependent diabetes mellitus - With renal complications | 1225 | |
| PURCH | PURCH_ATC(A10BX07) | Liraglutide | 1202 | |
| OUTPAT | OUTPAT_ICD10(E1100) | Non-insulin dependent diabetes diabetic hypoglycaemic coma | 1198 | |
| PURCH | PURCH_ATC(A10BB07) | Glipizide | 1186 | |
| INPAT | INPAT_ICD10(E11) | Non-insulin-dependent diabetes mellitus | 1077 | |
| PURCH | PURCH_ATC(A10BX02) | Repaglinide | 992 | |
| PURCH | PURCH_ATC(A10BX04) | Exenatide | 964 | |
| OUTPAT | OUTPAT_ICD10(E115) | Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications | 886 | |
| INPAT | INPAT_ICD10(E115) | Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications | 854 | |
| INPAT | INPAT_ICD10(E112) | Non-insulin-dependent diabetes mellitus - With renal complications | 824 | |
| REIMB | REIMB_KELA(177)_ICD10(E11) | Insulin glargine 300 U / ml, Non-insulin-dependent diabetes mellitus | 822 | |
| OUTPAT | OUTPAT_ICD10(E114) | Non-insulin-dependent diabetes mellitus - With neurological complications | 807 | |
| PURCH | PURCH_ATC(A10BX09) | Dapagliflozin | 804 | |
| REIMB | REIMB_KELA(162)_ICD10(E11) | liraglutide, Non-insulin-dependent diabetes mellitus | 794 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(E116) | Non-insulin-dependent diabetes mellitus - With other specified complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 785 | |
| PURCH | PURCH_ATC(A10BJ01) | Exenatide | 759 | |
| PURCH | PURCH_ATC(A10BJ06) | Name not found | 757 | |
| PURCH | PURCH_ATC(A10BD08) | Metformin and vildagliptin | 719 | |
| REIMB | REIMB_KELA(285)_ICD10(E119) | Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - Without complications | 590 | |
| REIMB | REIMB_KELA(103)_ICD10(E118) | Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With unspecified complications | 583 | |
| OUTPAT | OUTPAT_ICD10(E116) | Non-insulin-dependent diabetes mellitus - With other specified complications | 579 | |
| REIMB | REIMB_KELA(215)_ICD10(E118) | Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With unspecified complications | 575 | |
| INPAT | INPAT_ICD10(E116) | Non-insulin-dependent diabetes mellitus - With other specified complications | 529 | |
| PURCH | PURCH_ATC(A10BJ05) | Dulaglutide | 518 | |
| INPAT | INPAT_ICD10(E113) | Non-insulin-dependent diabetes mellitus - With ophthalmic complications | 513 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(E115) | Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 509 | |
| PURCH | PURCH_ATC(A10BD20) | Metformin and empagliflozin | 498 | |
| REIMB | REIMB_KELA(346)_ICD10(E119) | Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - Without complications | 471 | |
| DEATH | DEATH_ICD10(E117) | Non-insulin-dependent diabetes mellitus - With multiple complications | 464 | |
| INPAT | INPAT_ICD10(E114) | Non-insulin-dependent diabetes mellitus - With neurological complications | 421 | |
| PURCH | PURCH_ATC(A10BD15) | Metformin and dapagliflozin | 405 | |
| PURCH | PURCH_ATC(A10BD05) | Metformin and pioglitazone | 404 | |
| DEATH | DEATH_ICD10(E118) | Non-insulin-dependent diabetes mellitus - With unspecified complications | 378 | |
| REIMB | REIMB_KELA(358)_ICD10(E11) | liraglutide, Non-insulin-dependent diabetes mellitus | 337 | |
| REIMB | REIMB_KELA(310)_ICD10(E11) | Orlistat, sibutramine and other major and expensive medicines used to treat obesity, Non-insulin-dependent diabetes mellitus | 314 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(E1100) | Non-insulin dependent diabetes diabetic hypoglycaemic coma. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 261 | |
| PURCH | PURCH_ATC(A10BD11) | Metformin and linagliptin | 235 | |
| REIMB | REIMB_KELA(160)_ICD10(E119) | exenatide, Non-insulin-dependent diabetes mellitus - Without complications | 232 | |
| DEATH | DEATH_ICD10(E112) | Non-insulin-dependent diabetes mellitus - With renal complications | 192 | |
| REIMB | REIMB_KELA(162)_ICD10(E119) | liraglutide, Non-insulin-dependent diabetes mellitus - Without complications | 171 | |
| INPAT | INPAT_ICD10(E111) | Non-insulin-dependent diabetes mellitus - With ketoacidosis | 160 | |
| PURCH | PURCH_ATC(A10BH03) | Saxagliptin | 160 | |
| INPAT | INPAT_ICD9(2507A) | Diabetes mellitus, Diabetes with peripheral circulatory disorders | 140 | |
| OUTPAT | OUTPAT_ICD10(E111) | Non-insulin-dependent diabetes mellitus - With ketoacidosis | 137 | |
| OUTPAT | OUTPAT_ICD10(E1101) | Non-insulin dependent diabetes diabetic coma with hyperglycaemia | 117 | |
| INPAT | INPAT_ICD10(E1109) | Non-insulin-dependent diabetes mellitus - With coma | 111 | |
| INPAT | INPAT_ICD9(2505A) | Diabetes mellitus, Diabetes with ophthalmic manifestations | 106 | |
| PURCH | PURCH_ATC(A10BX12) | Empagliflozin | 104 | |
| REIMB | REIMB_KELA(358)_ICD10(E119) | liraglutide, Non-insulin-dependent diabetes mellitus - Without complications | 84 | |
| REIMB | REIMB_KELA(285)_ICD10(E117) | Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With multiple complications | 82 | |
| OUTPAT | OUTPAT_ICD10(E1109) | Non-insulin-dependent diabetes mellitus - With coma | 78 | |
| REIMB | REIMB_KELA(103)_ICD10(E112) | Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With renal complications | 73 | |
| REIMB | REIMB_KELA(215)_ICD10(E112) | Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With renal complications | 71 | |
| REIMB | REIMB_KELA(346)_ICD10(E118) | Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With unspecified complications | 70 | |
| DEATH | DEATH_ICD9(2500A) | Diabetes mellitus without mention of complication | 69 | |
| REIMB | REIMB_KELA(346)_ICD10(E117) | Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With multiple complications | 65 | |
| REIMB | REIMB_KELA(285)_ICD10(E118) | Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With unspecified complications | 64 | |
| REIMB | REIMB_KELA(103)_ICD10(E117) | Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With multiple complications | 60 | |
| DEATH | DEATH_ICD10(E115) | Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications | 57 | |
| INPAT | INPAT_ICD10(E1101) | Non-insulin dependent diabetes diabetic coma with hyperglycaemia | 57 | |
| REIMB | REIMB_KELA(103)_ICD10(E114) | Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With neurological complications | 56 | |
| REIMB | REIMB_KELA(215)_ICD10(E114) | Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With neurological complications | 55 | |
| REIMB | REIMB_KELA(103)_ICD10(E116) | Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With other specified complications | 53 | |
| REIMB | REIMB_KELA(346)_ICD10(E112) | Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With renal complications | 51 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(E111) | Non-insulin-dependent diabetes mellitus - With ketoacidosis. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 50 | |
| REIMB | REIMB_KELA(215)_ICD10(E116) | Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With other specified complications | 50 | |
| REIMB | REIMB_KELA(285)_ICD10(E112) | Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With renal complications | 50 | |
| PURCH | PURCH_ATC(A10BD19) | Linagliptin and empagliflozin | 48 | |
| REIMB | REIMB_KELA(215)_ICD10(E117) | Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With multiple complications | 47 | |
| REIMB | REIMB_KELA(177)_ICD10(E119) | Insulin glargine 300 U / ml, Non-insulin-dependent diabetes mellitus - Without complications | 46 | |
| DEATH | DEATH_ICD10(E116) | Non-insulin-dependent diabetes mellitus - With other specified complications | 44 | |
| PURCH | PURCH_ATC(A10BH04) | Alogliptin | 44 | |
| PURCH | PURCH_ATC(A10BX03) | Nateglinide | 41 | |
| REIMB | REIMB_KELA(103)_ICD9(E11) | Diabetes, insulin-treated, Name not found | 37 | |
| INPAT | INPAT_ICD9(2503A) | Diabetes mellitus, Diabetes with other coma | 35 | |
| PURCH | PURCH_ATC(A10BD10) | Metformin and saxagliptin | 35 | |
| INPAT | INPAT_ICD9(2506A) | Diabetes mellitus, Diabetes with neurological manifestations | 34 | |
| REIMB | REIMB_KELA(103)_ICD10(E113) | Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With ophthalmic complications | 33 | |
| INPAT | INPAT_ICD9(2508A) | Diabetes mellitus, Diabetes with other specified manifestations | 32 | |
| REIMB | REIMB_KELA(346)_ICD10(E113) | Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With ophthalmic complications | 32 | |
| DEATH | DEATH_ICD10(E110) | Name not found | 31 | |
| REIMB | REIMB_KELA(103)_ICD10(E110) | Diabetes, insulin-treated, Name not found | 31 | |
| REIMB | REIMB_KELA(215)_ICD10(E113) | Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With ophthalmic complications | 31 | |
| REIMB | REIMB_KELA(285)_ICD10(E113) | Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With ophthalmic complications | 31 | |
| PURCH | PURCH_ATC(A10BK02) | Kanagliflozin | 30 | |
| DEATH | DEATH_ICD10(E114) | Non-insulin-dependent diabetes mellitus - With neurological complications | 28 | |
| REIMB | REIMB_KELA(215)_ICD10(E110) | Diabetes, non-insulin-treated, Name not found | 27 | |
| REIMB | REIMB_KELA(160)_ICD10(E117) | exenatide, Non-insulin-dependent diabetes mellitus - With multiple complications | 26 | |
| REIMB | REIMB_KELA(285)_ICD10(E114) | Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With neurological complications | 26 | |
| DEATH | DEATH_ICD9(2507A) | Diabetes mellitus, Diabetes with peripheral circulatory disorders | 25 | |
| REIMB | REIMB_KELA(346)_ICD10(E114) | Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With neurological complications | 24 | |
| INPAT | INPAT_ICD9(2504A) | Diabetes mellitus, Diabetes with renal manifestations | 23 | |
| REIMB | REIMB_KELA(162)_ICD10(E117) | liraglutide, Non-insulin-dependent diabetes mellitus - With multiple complications | 23 | |
| REIMB | REIMB_KELA(162)_ICD10(E112) | liraglutide, Non-insulin-dependent diabetes mellitus - With renal complications | 22 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(E1109) | Non-insulin-dependent diabetes mellitus - With coma. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 20 | |
| REIMB | REIMB_KELA(160)_ICD10(E112) | exenatide, Non-insulin-dependent diabetes mellitus - With renal complications | 20 | |
| REIMB | REIMB_KELA(162)_ICD10(E118) | liraglutide, Non-insulin-dependent diabetes mellitus - With unspecified complications | 20 | |
| REIMB | REIMB_KELA(103)_ICD10(E111) | Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With ketoacidosis | 19 | |
| REIMB | REIMB_KELA(160)_ICD10(E118) | exenatide, Non-insulin-dependent diabetes mellitus - With unspecified complications | 19 | |
| REIMB | REIMB_KELA(215)_ICD10(E111) | Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With ketoacidosis | 16 | |
| PURCH | PURCH_ATC(A10BD09) | Pioglitazone and alogliptin | 15 | |
| DEATH | DEATH_ICD10(E111) | Non-insulin-dependent diabetes mellitus - With ketoacidosis | 14 | |
| OUTPAT | OUTPAT_ICD10(E110) | Name not found | 14 | |
| PURCH | PURCH_ATC(A10BD13) | Metformin and alogliptin | 14 | |
| REIMB | REIMB_KELA(285)_ICD10(E116) | Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With other specified complications | 14 | |
| REIMB | REIMB_KELA(358)_ICD10(E112) | liraglutide, Non-insulin-dependent diabetes mellitus - With renal complications | 14 | |
| DEATH | DEATH_ICD10(E113) | Non-insulin-dependent diabetes mellitus - With ophthalmic complications | 13 | |
| PURCH | PURCH_ATC(A10BJ03) | Lixisenatide | 12 | |
| PURCH | PURCH_ATC(A10BK04) | Name not found | 12 | |
| REIMB | REIMB_KELA(160)_ICD10(E114) | exenatide, Non-insulin-dependent diabetes mellitus - With neurological complications | 12 | |
| PURCH | PURCH_ATC(A10BD21) | Saxagliptin and dapagliflozin | 11 | |
| REIMB | REIMB_KELA(103)_ICD10(E115) | Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications | 11 | |
| REIMB | REIMB_KELA(346)_ICD10(E116) | Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With other specified complications | 10 | |
| REIMB | REIMB_KELA(160)_ICD10(E113) | exenatide, Non-insulin-dependent diabetes mellitus - With ophthalmic complications | 9 | |
| REIMB | REIMB_KELA(162)_ICD10(E114) | liraglutide, Non-insulin-dependent diabetes mellitus - With neurological complications | 9 | |
| REIMB | REIMB_KELA(215)_ICD10(E115) | Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications | 9 | |
| REIMB | REIMB_KELA(310)_ICD10(E119) | Orlistat, sibutramine and other major and expensive medicines used to treat obesity, Non-insulin-dependent diabetes mellitus - Without complications | 8 | |
| PURCH | PURCH_ATC(A10BB02) | Chlorpropamide | 7 | |
| PURCH | PURCH_ATC(A10BX10) | Lixisenatid | 7 | |
| REIMB | REIMB_KELA(358)_ICD10(E117) | liraglutide, Non-insulin-dependent diabetes mellitus - With multiple complications | 7 | |
| REIMB | REIMB_KELA(160)_ICD10(E116) | exenatide, Non-insulin-dependent diabetes mellitus - With other specified complications | 6 | |
| REIMB | REIMB_KELA(162)_ICD10(E113) | liraglutide, Non-insulin-dependent diabetes mellitus - With ophthalmic complications | 6 | |
| REIMB | REIMB_KELA(177)_ICD10(E118) | Insulin glargine 300 U / ml, Non-insulin-dependent diabetes mellitus - With unspecified complications | 6 | |
| DEATH | DEATH_ICD9(2505A) | Diabetes mellitus, Diabetes with ophthalmic manifestations | 5 | |
| DEATH | DEATH_ICD9(2506A) | Diabetes mellitus, Diabetes with neurological manifestations | 5 | |
| DEATH | DEATH_ICD9(2508A) | Diabetes mellitus, Diabetes with other specified manifestations | 5 | |
| REIMB | REIMB_KELA(285)_ICD10(E115) | Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications | 5 |